Search results for "GF"

showing 10 items of 838 documents

Ab initio calculations of pure and Co+2-doped MgF2 crystals

2020

This research was partly supported by the Kazakhstan Science Project № AP05134367«Synthesis of nanocrystals in track templates of SiO2/Si for sensory, nano- and optoelectronic applications», as well as by Latvian Research Council project lzp-2018/1-0214. Calculations were performed on Super Cluster (LASC) in the Institute of Solid State Physics (ISSP) of the University of Latvia. Authors are indebted to S. Piskunov for stimulating discussions.

AB INITIO CALCULATIONSNuclear and High Energy PhysicsMaterials scienceSpin statesBand gapAb initioENERGY GAP02 engineering and technologyFLUORINE COMPOUNDS01 natural sciences7. Clean energyMolecular physicsAb initio quantum chemistry methodsCobalt dopant0103 physical sciencesPhysics::Atomic and Molecular Clusters:NATURAL SCIENCES:Physics [Research Subject Categories]MgF2010306 general physicsFluorideInstrumentationCOBALT DOPANTSDopantCRYSTAL ATOMIC STRUCTUREDopingCOBALT COMPOUNDSMAGNESIUM COMPOUNDSDOPANT ENERGY LEVELS021001 nanoscience & nanotechnologyVIBRATIONAL STRUCTURESCALCULATIONSCRYSTALSGROUND STATELinear combination of atomic orbitalsCELL PROLIFERATIONAb initioGROUND STATE LEVELS0210 nano-technologyGround state
researchProduct

Sprint and endurance training in relation to redox and inflammatory status and biomarkers of aging in master athletes

2020

Purpose Studies have shown a positive influence of intense athletic training on several biomarkers of aging, but it remains unclear whether this influence is dependent of exercise-training-mode. This study compared redox balance, cytokine levels and biomarkers of aging between master sprinters and endurance athletes, as well as in young and middle-aged individuals as controls. Methods Participants were male master sprinters (SA, 50±8.9yrs; n=13) and endurance runners (EA, 53±8.2yrs; n=18) with remarkable athletic experience (∼25yrs of practice), besides untrained young (YC, 22.7±3.9yrs; n=17) and age-matched controls (MC, 45.5±9.8yrs; n=12). Anamnesis, anthropometrics, biomarkers of aging, …

ADMAmaster athletestulehduskestävyysharjoitteluoxidative stressklotho-FGF-23biomarkkeritirisincytokineshapenotto
researchProduct

Contribución de IGF-I en la hiperplasia mamaria promovida por AIB1

2015

El oncogén AIB1 (Amplified in Breast Cancer 1) es un coactivador de la transcripción de genes implicados en la respuesta fisiológica a hormonas y factores de crecimiento. La sobreexpresión de AIB1 es una característica frecuente en muchos tipos de cáncer, incluyendo el de mama. Diferentes estudios con líneas celulares y modelos animales han demostrado que AIB1 interacciona con la ruta de señalización de IGF-I/PI3K/AKT a diferentes niveles moleculares. Por otra parte, la señalización mediada por IGF-I a través de su receptor IGF-IR juega un papel muy importante en el desarrollo de la glándula mamaria y en los procesos patológicos que ocurren en este tejido. Debido a esto, existen múltiples i…

AIB1OncogénUNESCO::CIENCIAS MÉDICASHiperplasia mamaria:CIENCIAS MÉDICAS [UNESCO]IGF-I
researchProduct

Low-Cost Synthesis of Smart Biocompatible Graphene Oxide Reduced Species by Means of GFP.

2015

The aim of this work is focused on the engineering of biocompatible complex systems composed of an inorganic and bio part. Graphene oxide (GO) and/or graphite oxide (GtO) were taken into account as potential substrates to the linkage of the protein such as Anemonia sulcata recombinant green fluorescent protein (rAsGFP). The complex system is obtained through a reduction process between GO/GtO and rAsGFP archiving an environmentally friendly biosynthesis. Spectroscopic measurements support the formation of reduced species. In particular, photoluminescence shows a change in the activity of the protein when a bond is formed, highlighted by a loss of the maximum emission signal of rAsGFP and a …

Absorption (pharmacology)HemolysiPhotoluminescenceMaterials scienceBiocompatibilityGreen Fluorescent ProteinsOxideNanotechnologyGraphite oxideBioengineeringBiocompatible Materials02 engineering and technology010402 general chemistryGFP01 natural sciencesBiochemistryApplied Microbiology and Biotechnologylaw.inventionchemistry.chemical_compoundlawGraphiteMolecular BiologyGraphene oxideReductionGraphenegraphene oxide; graphite oxide; GFP; reduction; biocompatibility; hemolysisOxidesGeneral Medicine021001 nanoscience & nanotechnology0104 chemical scienceschemistryChemical engineeringDrug deliveryGraphite oxideBiocompatibilityGraphite0210 nano-technologyBiotechnologyApplied biochemistry and biotechnology
researchProduct

IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells

2007

Regulatory T (T(reg)) cells play a key role in the maintenance of the immune system homeostasis. T(reg) cells can be generated in the periphery under control of TGF-beta, a cytokine involved in the negative control of the immune system. However, TGF-beta cooperates with IL-6 in the generation of Th17 cells, a novel class of effector cells involved in numerous inflammatory diseases, including colitis. Therefore, TGF-beta emerges as a mediator of both anti-inflammatory and pro-inflammatory processes, depending on the local cytokine milieu. Here we demonstrate that IL-21, a type-1 cytokine produced by T cells and involved in the pathogenesis of immune-mediated diseases, prevents the TGF-beta-d…

Adoptive cell transfermedicine.medical_treatmentImmunologyCellGene Expressionchemical and pharmacologic phenomenaMice SCIDBiologyT-Lymphocytes RegulatoryMiceImmune systemT-Lymphocyte SubsetsTransforming Growth Factor betaFoxP3IL-21medicineAnimalsImmunology and AllergyRNA MessengerIL-2 receptorTranscription factorSettore MED/12 - GastroenterologiaMice Inbred BALB CReverse Transcriptase Polymerase Chain ReactionInterleukinsInterleukin-17FOXP3Forkhead Transcription Factorshemic and immune systemsColitisFlow CytometryAdoptive TransferCell biologyColitis; FoxP3; IL-21; Treg cells; TGF-βTGF-βDisease Models Animalmedicine.anatomical_structureCytokineImmunologyTreg cellsHomeostasisEuropean Journal of Immunology
researchProduct

CD4+CD25+ Regulatory T Cells and TGF-Beta in Mucosal Inflammation

2008

Transforming growth factor-beta (TGF-beta) is an anti-inflammatory cytokine which plays a key role in the maintenance of the immune system homeostasis. Indeed the abrogation of the TGF-beta signaling in immune cells leads to autoimmunity and inflammation in several organs including the gut. TGF-beta acts at multiple levels to maintain the immune system in check. However, TGF-beta has been recently shown to play a key role in the peripheral generation and function of CD4+CD25+ regulatory T cells, a subset of suppressive lymphocytes involved in the control of effector T cell activation and proliferation. Consistently abrogation of Tregs maturation as observed in different systems leads to a p…

Adoptive cell transfermedicine.medical_treatmentT cellInflammationBiologymedicine.disease_causeCell biologyAutoimmunityImmune systemCytokinemedicine.anatomical_structureTGF beta signaling pathwaymedicineIL-2 receptormedicine.symptom
researchProduct

SHIP2: A “NEW” Insulin Pathway Target for Aging Research

2014

Strong evidence suggests that systemic inflammation and central adiposity contribute to and perpetuate metabolic syndrome. All of these alterations predispose individuals to type 2 diabetes mellitus (T2DM), cardiovascular disease, as well as Alzheimer's disease (AD), all characterized by chronic inflammatory status. On the other hand, extensive abnormalities in insulin and insulin-like growth factor I (IGF-I) and IGF-II signaling mechanisms in brains with AD have been demonstrated, suggesting that AD could be a third form of diabetes. The Src homology domain-containing inositol 5-phosphatase 2 (SHIP2) has an important role in the insulin pathway because its over-expression causes impairment…

AdultAgingmedicine.medical_specialtymedicine.medical_treatmentDiseaseBiologySystemic inflammationPolymorphism Single Nucleotidepolymorphismchemistry.chemical_compounddomain-containing inositol 5-phosphatase 2 (SHIP2) insulin-like growth factor I (IGF-I) type 2 diabetes mellitus (T2DM)INFLAMMATIONGene FrequencyAlzheimer DiseaseDiabetes mellitusInternal medicinemedicineHumansInsulinSettore MED/05 - Patologia ClinicaSNPInositolAgedSettore MED/04 - Patologia GeneraleALZHEIMER’S DISEASEResearchInsulinInositol Polyphosphate 5-PhosphatasesNEURODEGENERATIONType 2 Diabetes Mellitusmedicine.diseasePhosphoric Monoester HydrolasesEndocrinologyDiabetes Mellitus Type 2chemistryImmunologySettore MED/26 - NeurologiaGeriatrics and Gerontologymedicine.symptomMetabolic syndromeSignal TransductionRejuvenation Research
researchProduct

Combination of the mTOR inhibitor ridaforolimus and the anti-IGF1R monoclonal antibody dalotuzumab: preclinical characterization and phase I clinical…

2014

Abstract Purpose: Mammalian target of rapamycin (mTOR) inhibition activates compensatory insulin–like growth factor receptor (IGFR) signaling. We evaluated the ridaforolimus (mTOR inhibitor) and dalotuzumab (anti-IGF1R antibody) combination. Experimental Design: In vitro and in vivo models, and a phase I study in which patients with advanced cancer received ridaforolimus (10–40 mg/day every day × 5/week) and dalotuzumab (10 mg/kg/week or 7.5 mg/kg/every other week) were explored. Results: Preclinical studies demonstrated enhanced pathway inhibition with ridaforolimus and dalotuzumab. With 87 patients treated in the phase I study, main dose-limiting toxicities (DLT) of the combination were p…

AdultCancer ResearchPhases of clinical researchBreast NeoplasmsPharmacologyAntibodies Monoclonal HumanizedArticleReceptor IGF Type 1Ridaforolimuschemistry.chemical_compoundBreast cancerIn vivoAntineoplastic Combined Chemotherapy ProtocolsMedicineAnimalsHumansPI3K/AKT/mTOR pathwayInsulin-like growth factor 1 receptorAgedSirolimusDalotuzumabbusiness.industryTOR Serine-Threonine KinasesAntibodies MonoclonalReceptors SomatomedinMiddle Agedmedicine.diseaseXenograft Model Antitumor AssaysOncologychemistryMonoclonalbusinessSignal TransductionClinical cancer research : an official journal of the American Association for Cancer Research
researchProduct

Association between IGF-1 levels ranges and all-cause mortality: A meta-analysis

2022

The association between IGF-1 levels and mortality in humans is complex with low levels being associated with both low and high mortality. The present meta-analysis investigates this complex relationship between IGF-1 and all-cause mortality in prospective cohort studies. A systematic literature search was conducted in PubMed/MEDLINE, Scopus, and Cochrane Library up to September 2019. Published studies were eligible for the meta-analysis if they had a prospective cohort design, a hazard ratio (HR) and 95% confidence interval (CI) for two or more categories of IGF-1 and were conducted among adults. A random-effects model with a restricted maximum likelihood heterogeneity variance estimator w…

AdultCohort StudiesAgingIGF-1HumansCell BiologyProspective StudiesInsulin-Like Growth Factor Imortalityprotein intakeProportional Hazards Models
researchProduct

IGF-I, IgA, and IgG responses to bovine colostrum supplementation during training.

2002

This study examined the effect of bovine colostrum (Dynamic colostrum) supplementation on blood and saliva variables ( study 1) and the absorption of orally administered human recombinant insulin-like growth factor (IGF)-I (rhIGF-I) labeled with 123I (123I-rhIGF-I) ( study 2). In study 1, adult male and female athletes were randomly assigned in a double-blind fashion to either an experimental (Dynamic; n = 19) or a control (Placebo; n = 11) group. The former consumed daily 20 g of Dynamic supplement, and the latter 20 g of maltodextrin during a 2-wk training period. After bovine colostrum supplementation, significant increases were noticed in serum IGF-I ( P < 0.01) and saliva IgA ( P &…

AdultElectrophoresisMaleSalivamedicine.medical_specialtyPhysiologyCausticsAnimal originlaw.inventionReceptor IGF Type 1Iodine RadioisotopesDouble-Blind MethodlawPhysiology (medical)Internal medicinemedicineAnimalsHumansInsulin-Like Growth Factor ITrichloroacetic AcidSalivabusiness.industryColostrumImmunoglobulin AEndocrinologyNutrition AssessmentPhysical performancePhysical FitnessImmunoglobulin GDietary SupplementsRecombinant DNAColostrumCattleFemalebusinessJournal of applied physiology (Bethesda, Md. : 1985)
researchProduct